Scarica l'app Stockscreener
33.96
0.85%
-0.29
Dopo l'orario di chiusura:
33.96
Precedente Chiudi:
$34.25
Aprire:
$34.05
Volume 24 ore:
1.46M
Relative Volume:
0.71
Capitalizzazione di mercato:
$7.00B
Reddito:
$2.09B
Utile/perdita netta:
$424.88M
Rapporto P/E:
16.62
EPS:
2.0439
Flusso di cassa netto:
$447.20M
1 W Prestazione:
-10.84%
1M Prestazione:
-17.23%
6M Prestazione:
-23.10%
1 anno Prestazione:
-21.26%
Intervallo 1D:
$33.62
$34.23
Intervallo di 1 settimana:
$33.17
$35.58
Portata 52W:
$33.17
$57.81
Qiagen Nv Stock (QGEN) Company Profile
Nome
Qiagen Nv
Settore
Industria
Telefono
-
Indirizzo
-
Compare QGEN vs TMO, DHR, IDXX, A, NTRA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
33.96 | 7.06B | 2.09B | 424.88M | 447.20M | 2.0439 |
TMO
Thermo Fisher Scientific Inc
|
462.60 | 174.37B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
174.04 | 123.97B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
563.12 | 45.07B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
112.18 | 32.36B | 7.07B | 1.29B | 993.00M | 4.5355 |
NTRA
Natera Inc
|
211.56 | 29.60B | 2.31B | -208.16M | 76.11M | -1.5366 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-14 | Downgrade | Barclays | Overweight → Equal Weight |
| 2026-03-13 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2025-06-24 | Iniziato | Barclays | Overweight |
| 2025-04-04 | Downgrade | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-10-17 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-06-27 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-12-07 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-09-12 | Iniziato | Robert W. Baird | Outperform |
| 2023-05-23 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Aggiornamento | DZ Bank | Hold → Buy |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-10-14 | Iniziato | Redburn | Buy |
| 2021-07-14 | Downgrade | Kepler | Buy → Hold |
| 2021-06-03 | Iniziato | Goldman | Neutral |
| 2020-10-06 | Ripresa | BofA Securities | Buy |
| 2020-09-28 | Aggiornamento | Kepler | Hold → Buy |
| 2020-08-24 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-08-17 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-08-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Downgrade | Berenberg | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-12-26 | Ripresa | BofA/Merrill | Underperform |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-11-14 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Aggiornamento | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Aggiornamento | Kepler | Reduce → Hold |
| 2019-10-17 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Downgrade | Kepler | Hold → Reduce |
| 2019-10-08 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Downgrade | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
Mostra tutto
Qiagen Nv Borsa (QGEN) Ultime notizie
QIAGEN NV Hits Day Low of $33.82 Amid Price Pressure - Markets Mojo
Primer: QIAGEN NV (QIA GY)May 2026 - Smartkarma
QIAGEN NV : Jefferies maintains a Buy rating - marketscreener.com
How The Qiagen (QGEN) Investment Story Is Shifting As Analysts Rework Their Assumptions - Yahoo Finance
Qiagen Trims 2026 Outlook After Mixed Q1 and QuantiFERON Weakness - TipRanks
Qiagen (NYSE:QGEN) Upgraded by Zacks Research to "Hold" Rating - MarketBeat
QGEN Stock Price, Quote & Chart | QIAGEN N.V. (NYSE:QGEN) - ChartMill
QIAGEN NV cuts FY outlook despite in-line prelim Q1 EPS - MSN
QIAGEN N.V. (QGEN.US) will release its earnings report after the market closes on May 6. - Moomoo
Lower QuantiFERON demand leads QIAGEN (NYSE: QGEN) to trim 2026 outlook - Stock Titan
A Quick Look at Today's Ratings for Qiagen NV(QGEN.US), With a Forecast Between $38 to $45 - Moomoo
MSN Money - MSN
Robert W. Baird Upgrades Qiagen (NYSE:QGEN) to Strong-Buy - MarketBeat
Morgan Stanley Maintains Qiagen NV(QGEN.US) With Hold Rating, Cuts Target Price to $39.69 - Moomoo
Qiagen Shares Plunge 10.7 Percent to Seven Year Low - HarianBasis.co
Pictet Asset Management Holding SA Reduces Holdings in Qiagen N.V. $QGEN - MarketBeat
Baird upgrades Qiagen NV (QGEN) - MSN
Qiagen Is Maintained at Overweight by JP Morgan - Moomoo
Barclays downgrades Qiagen NV (QGEN) - MSN
QGEN Maintained by JP Morgan -- Price Target Lowered to $45 - GuruFocus
QGEN Maintained by Citigroup -- Price Target Lowered to $38.00 - GuruFocus
JPMorgan Chase & Co. Has Lowered Expectations for Qiagen (NYSE:QGEN) Stock Price - MarketBeat
Citigroup Lowers Qiagen (NYSE:QGEN) Price Target to $38.00 - MarketBeat
QGEN Maintained by Barclays -- Price Target Lowered to $38.00 - GuruFocus
Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight - GlobeNewswire Inc.
Citi Maintains Qiagen NV(QGEN.US) With Hold Rating, Cuts Target Price to $38 - Moomoo
QIAGEN NV Hits 52-Week Low at USD 33.82 Amidst Declining Performance - Markets Mojo
Morgan Stanley Cuts Price Target on QIAGEN to $40 From $51, Keeps Equalweight Rating - marketscreener.com
QGEN Upgraded by Baird -- Price Target Lowered to $43.00 - GuruFocus
Baird Upgrades QIAGEN to Outperform From Neutral, Cuts Price Target to $43 From $53 - marketscreener.com
Qiagen Sets Date for Publication of 2025 Annual Financial Report - The Globe and Mail
QIAGEN NV : DZ Bank gives a Buy rating - marketscreener.com
Qiagen (QGEN) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Qiagen (NYSE:QGEN) Sets New 12-Month LowShould You Sell? - MarketBeat
Qiagen N.V. (NYSE:QGEN) Receives Average Rating of "Hold" from Analysts - MarketBeat
Qiagen NV (QGEN) Q1 2026 Earnings Call Highlights: Navigating Mi - GuruFocus
Baird upgrades Qiagen stock rating on valuation after pullback By Investing.com - Investing.com India
Stifel Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $50 - Moomoo
Baird upgrades Qiagen stock rating on valuation after pullback - Investing.com
QIAGEN NV : Barclays reiterates its Neutral rating - marketscreener.com
Baird Upgrades Qiagen NV (QGEN) to Outperform - StreetInsider
Is Qiagen NV (QGEN) a Bargain After 10.7% Drop? GF Value Says Un - GuruFocus
Qiagen NV (QGEN) Falls to 7-Year Low as MidEast Tensions Drag Q1 - Yahoo Finance
Qiagen N.V. Shareholders Are Encouraged to Reach Out to - GlobeNewswire
Earnings Call Summary | Qiagen NV(QGEN.US) Q1 2026 Earnings Conference - Moomoo
QIAGEN NV : Jefferies keeps its Buy rating - marketscreener.com
Qiagen NV (QGEN) PT Lowered to $38 at Barclays - StreetInsider
Qiagen (NYSE:QGEN) Sees Strong Trading VolumeShould You Buy? - MarketBeat
QIAGEN slides after cutting 2026 outlook, citing weaker QuantiFERON demand and cautious customer spending - Quiver Quantitative
German Shares Slip; Qiagen Tumbles on Outlook Downgrade - marketscreener.com
Qiagen N.V. 2026 Q1ResultsEarnings Call Presentation (NYSE:QGEN) 2026-04-28 - Seeking Alpha
Qiagen Nv Azioni (QGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.64%
0.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):